07-05-2022 11:51 AM | Source: Dion Global Solutions Ltd
Marksans Pharma spurts as board to mull share buyback
Marksans Pharma jumped 10.30% to Rs 47.65 after the company said that its board will consider a share buyback on Friday, 8 July 2022. As on 31 March 2022, promoters held 48.25% stake in the company. On a consolidated basis, the company reported a 62.7% fall in net profit to Rs 29.65 crore despite of a 26.6% rise in net sales to Rs 418.04 crore in Q4 FY22 over Q4 FY21. Marksans Pharma is an Indian pharmaceutical company having a global footprint. The company's strengths lie in research, manufacturing and marketing of finished dosage pharmaceutical formulations.
Latest News
Indian Overseas Bank: Harmonizing Progress through r...
Daily Commodity Market Outlook 06.05.2024 by Mr. An...
India Acts Swiftly: Duty on Chana Lifted, Import Win...
Thriving Harvests and Rainfall Realities: India's Su...
The Nifty Bank extended decline on Friday led by lar...
Factor based Mid and Smallcap Fund: Another First of...
REC gets RBI's nod to set up subsidiary in Gujarat's...
Nifty traded volatile for yet another day and lost n...
Dollar steady after soft US jobs report; yen starts ...
Oil nudges higher after Saudi Arabia hikes prices